BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30759278)

  • 21. Concentration-Dependent Dual Effects of Ciprofloxacin on SB-590885-Resistant BRAF
    Aldaghi SA; Jalal R
    Chem Res Toxicol; 2019 Apr; 32(4):645-658. PubMed ID: 30829029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxicity study and influence of SBA-15 surface polarity and pH on adsorption and release properties of anticancer agent pemetrexed.
    Almáši M; Beňová E; Zeleňák V; Madaj B; Huntošová V; Brus J; Urbanová M; Bednarčík J; Hornebecq V
    Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110552. PubMed ID: 32228921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent Advancements in Organotin(IV) Complexes as Potential Anticancer Agents.
    Devi J; Yadav J
    Anticancer Agents Med Chem; 2018; 18(3):335-353. PubMed ID: 29110624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triphenyltin(IV) benzoates with diazenyl/imino scaffold exhibiting remarkable apoptosis mediated by reactive oxygen species.
    Basu Baul TS; Dutta D; Duthie A; Prasad R; Rana NK; Koch B; Tiekink ERT
    J Inorg Biochem; 2017 Aug; 173():79-92. PubMed ID: 28505480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Verapamil delivery systems on the basis of mesoporous ZSM-5/KIT-6 and ZSM-5/SBA-15 polymer nanocomposites as a potential tool to overcome MDR in cancer cells.
    Popova M; Mihaylova R; Momekov G; Momekova D; Lazarova H; Trendafilova I; Mitova V; Koseva N; Mihályi J; Shestakova P; St Petkov P; Aleksandrov HA; Vayssilov GN; Konstantinov S; Szegedi Á
    Eur J Pharm Biopharm; 2019 Sep; 142():460-472. PubMed ID: 31336182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Antitumor Agents Based on Fluorescent Benzofurazan Derivatives and Mesoporous Silica.
    Tudose M; Culita DC; Baratoiu-Carpen RD; Mitran RA; Kuncser A; Romanitan C; Popescu RC; Savu DI
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisplatin-cyclooxygenase inhibitor conjugates, free and immobilised in mesoporous silica SBA-15, prove highly potent against triple-negative MDA-MB-468 breast cancer cell line.
    Predarska I; Saoud M; Morgan I; Eichhorn T; Kaluđerović GN; Hey-Hawkins E
    Dalton Trans; 2022 Jan; 51(3):857-869. PubMed ID: 34877948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organotin(IV) complexes derived from Schiff base N'-[(1E)-(2-hydroxy-3-methoxyphenyl)methylidene]pyridine-4-carbohydrazone: synthesis, in vitro cytotoxicities and DNA/BSA interaction.
    Hong M; Geng H; Niu M; Wang F; Li D; Liu J; Yin H
    Eur J Med Chem; 2014 Oct; 86():550-61. PubMed ID: 25216377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Licochalcone D induces apoptosis and inhibits migration and invasion in human melanoma A375 cells.
    Si L; Yan X; Hao W; Ma X; Ren H; Ren B; Li D; Dong Z; Zheng Q
    Oncol Rep; 2018 May; 39(5):2160-2170. PubMed ID: 29565458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
    Sirajuddin M; McKee V; Tariq M; Ali S
    Eur J Med Chem; 2018 Jan; 143():1903-1918. PubMed ID: 29133050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineering Mesoporous Silica Nanoparticles for Targeted Alpha Therapy against Breast Cancer.
    Pallares RM; Agbo P; Liu X; An DD; Gauny SS; Zeltmann SE; Minor AM; Abergel RJ
    ACS Appl Mater Interfaces; 2020 Sep; 12(36):40078-40084. PubMed ID: 32805833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cuprous oxide nanoparticle-inhibited melanoma progress by targeting melanoma stem cells.
    Yu B; Wang Y; Yu X; Zhang H; Zhu J; Wang C; Chen F; Liu C; Wang J; Zhu H
    Int J Nanomedicine; 2017; 12():2553-2567. PubMed ID: 28435246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of novel platinum(ii) based AIE compound-encapsulated mesoporous silica nanoparticles for cancer theranostic application.
    Pasha SS; Fageria L; Climent C; Rath NP; Alemany P; Chowdhury R; Roy A; Laskar IR
    Dalton Trans; 2018 Mar; 47(13):4613-4624. PubMed ID: 29517794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folate-conjugated hybrid SBA-15 particles for targeted anticancer drug delivery.
    Pang J; Zhao L; Zhang L; Li Z; Luan Y
    J Colloid Interface Sci; 2013 Apr; 395():31-9. PubMed ID: 23312579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hollow Mesoporous Silica@Metal-Organic Framework and Applications for pH-Responsive Drug Delivery.
    Jia X; Yang Z; Wang Y; Chen Y; Yuan H; Chen H; Xu X; Gao X; Liang Z; Sun Y; Li JR; Zheng H; Cao R
    ChemMedChem; 2018 Mar; 13(5):400-405. PubMed ID: 29337422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigating the effect of near infrared photo thermal therapy folic acid conjugated gold nano shell on melanoma cancer cell line A375.
    Majidi FS; Mohammadi E; Mehravi B; Nouri S; Ashtari K; Neshasteh-Riz A
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2161-2170. PubMed ID: 31159585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PLGA/SBA-15 mesoporous silica composite microparticles loaded with paclitaxel for local chemotherapy.
    Nanaki S; Siafaka PI; Zachariadou D; Nerantzaki M; Giliopoulos DJ; Triantafyllidis KS; Kostoglou M; Nikolakaki E; Bikiaris DN
    Eur J Pharm Sci; 2017 Mar; 99():32-44. PubMed ID: 27939620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic and immune-sensitizing properties of nitric oxide-modified Saquinavir in iNOS-positive human melanoma cells.
    Mijatovic S; Maksimovic-Ivanic D; Mojic M; Timotijevic G; Miljkovic D; Mangano K; Donia M; Di Cataldo A; Al-Abed Y; Cheng KF; Stosic-Grujicic S; Nicoletti F
    J Cell Physiol; 2011 Jul; 226(7):1803-12. PubMed ID: 21506111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.